165 related articles for article (PubMed ID: 18413420)
21. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes.
Nelson AE; Meinhardt U; Hansen JL; Walker IH; Stone G; Howe CJ; Leung KC; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
J Clin Endocrinol Metab; 2008 Jun; 93(6):2213-22. PubMed ID: 18381573
[TBL] [Abstract][Full Text] [Related]
22. The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men.
Velloso CP; Aperghis M; Godfrey R; Blazevich AJ; Bartlett C; Cowan D; Holt RI; Bouloux P; Harridge SD; Goldspink G
Growth Horm IGF Res; 2013 Jun; 23(3):76-80. PubMed ID: 23433656
[TBL] [Abstract][Full Text] [Related]
23. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
[TBL] [Abstract][Full Text] [Related]
24. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
25. Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.
Böhning D; Böhning W; Guha N; Cowan DA; Sönksen PH; Holt RI
BMC Med Res Methodol; 2016 Oct; 16(1):147. PubMed ID: 27793179
[TBL] [Abstract][Full Text] [Related]
26. Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse.
Krusenstjerna-Hafstrøm T; Rasmussen MH; Raschke M; Govender S; Madsen J; Christiansen JS
Growth Horm IGF Res; 2011 Dec; 21(6):331-5. PubMed ID: 21963127
[TBL] [Abstract][Full Text] [Related]
27. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.
Guha N; Cowan DA; Sönksen PH; Holt RI
Anal Bioanal Chem; 2013 Dec; 405(30):9669-83. PubMed ID: 23934394
[TBL] [Abstract][Full Text] [Related]
29. A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide.
Holt RI; Erotokritou-Mulligan I; Ridley SA; McHugh CM; Bassett EE; Cowan DA; Bartlett C; Sönksen PH
Growth Horm IGF Res; 2009 Feb; 19(1):43-50. PubMed ID: 18617430
[TBL] [Abstract][Full Text] [Related]
30. Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
Di Luigi L; Rigamonti AE; Agosti F; Mencarelli M; Sgrò P; Marazzi N; Cella SG; Müller EE; Sartorio A
Eur J Endocrinol; 2009 May; 160(5):753-8. PubMed ID: 19258430
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
[TBL] [Abstract][Full Text] [Related]
32. A follow-up of GH-dependent biomarkers during a 6-month period of the sporting season of male and female athletes.
Sartorio A; Jubeau M; Agosti F; Marazzi N; Rigamonti A; Müller EE; Maffiuletti NA
J Endocrinol Invest; 2006 Mar; 29(3):237-43. PubMed ID: 16682837
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport.
Abellan R; Ventura R; Pichini S; Pascual JA; Pacifici R; Di Carlo S; Bacosi A; Segura J; Zuccaro P
Clin Chem Lab Med; 2005; 43(1):75-85. PubMed ID: 15653447
[TBL] [Abstract][Full Text] [Related]
34. Tracking growth hormone abuse in sport: performance of marker proteins in a controlled setting.
Bosch J; Such-Sanmartín G; Segura J; Gutiérrez-Gallego R
Anal Chim Acta; 2012 Oct; 745():118-23. PubMed ID: 22938615
[TBL] [Abstract][Full Text] [Related]
35. Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples.
Pichini S; Ventura R; Palmi I; di Carlo S; Bacosi A; Langohr K; Abellan R; Pascual JA; Pacifici R; Segura J; Zuccaro P
J Pharm Biomed Anal; 2010 Dec; 53(4):1003-10. PubMed ID: 20674210
[TBL] [Abstract][Full Text] [Related]
36. Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report.
Sartorio A; Agosti F; Marazzi N; Maffiuletti NA; Cella SG; Rigamonti AE; Guidetti L; Di Luigi L; Muller EE
Clin Endocrinol (Oxf); 2004 Oct; 61(4):487-93. PubMed ID: 15473882
[TBL] [Abstract][Full Text] [Related]
37. Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests.
Nguyen TV; Nelson AE; Howe CJ; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
Clin Chem; 2008 Aug; 54(8):1268-76. PubMed ID: 18567697
[TBL] [Abstract][Full Text] [Related]
38. IGF-I abuse in sport: current knowledge and future prospects for detection.
Guha N; Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
[TBL] [Abstract][Full Text] [Related]
39. Detecting growth hormone abuse in athletes.
Holt RI
Anal Bioanal Chem; 2011 Aug; 401(2):449-62. PubMed ID: 21590497
[TBL] [Abstract][Full Text] [Related]
40. Statistical issues in implementing the marker method.
Bassett EE; Erotokritou-Mulligan I
Growth Horm IGF Res; 2009 Aug; 19(4):361-5. PubMed ID: 19515593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
